World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
73
Citations
18241
World Ranking
5959
National Ranking
186

Overview

Qidong You is affiliated with China Pharmaceutical University in China and has focused their research primarily in the fields of Biochemistry, Genetics and Molecular Biology, as well as Medicine. Their work spans 199 publications in the broader category of Biochemistry and 61 in Medicine, highlighting contributions to multiple interdisciplinary areas.

Their subfields of study include Molecular Biology, Oncology, Immunology, Organic Chemistry, and Hematology. These subfields show a specialization in molecular processes and disease-related research.

The main topics addressed in Qidong You's research cover a range of biochemical and therapeutic areas, including:

  • Protein Degradation and Inhibitors
  • Heat shock proteins research
  • Ubiquitin and proteasome pathways
  • Genomics, phytochemicals, and oxidative stress
  • RNA modifications and cancer
  • Histone Deacetylase Inhibitors Research
  • Click Chemistry and Applications

Qidong You has published frequently in several scientific journals. The most common venues include:

  • Journal of Medicinal Chemistry (36 publications)
  • European Journal of Medicinal Chemistry (22 publications)
  • Expert Opinion on Therapeutic Patents (7 publications)
  • Bioorganic & Medicinal Chemistry (6 publications)
  • Drug Discovery Today (5 publications)

Key recent papers authored by Qidong You demonstrate contributions across medicinal chemistry and cancer biology fields. These include:

  • Azo-PROTAC: Novel Light-Controlled Small-Molecule Tool for Protein Knockdown, 2020, Journal of Medicinal Chemistry
  • Regulation of Nrf2 by phosphorylation: Consequences for biological function and therapeutic implications, 2021, Free Radical Biology and Medicine
  • p62 as a therapeutic target for tumor, 2020, European Journal of Medicinal Chemistry
  • Targeting the HSP90-CDC37-kinase chaperone cycle: A promising therapeutic strategy for cancer, 2021, Medicinal Research Reviews
  • Beyond Proteolysis-Targeting Chimeric Molecules: Designing Heterobifunctional Molecules Based on Functional Effectors, 2022, Journal of Medicinal Chemistry

The scientist has collaborated extensively, with frequent coauthors including Zhengyu Jiang, Lei Wang, Xiaoke Guo, Qiuyue Zhang, and Xiaoli Xu. The number of joint publications with these coauthors ranges from 18 to 47, indicating ongoing research partnerships.

Best Publications

  • The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update.

    Meng-Chen Lu;Jian-Ai Ji;Zheng-Yu Jiang;Qi-Dong You

  • HIF-1α is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway

    Qiang L;Wu T;Zhang Hw;Lu N

  • Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR/Flk-1 of endothelial cells.

    Yun Ling;Yong Yang;Na Lu;Qi-dong You

  • Chiral Drugs: Chemistry and Biological Action

    Guo-Qiang Lin;Qi-Dong You;Jie-Fei Cheng

  • Discovery of a Keap1-dependent peptide PROTAC to knockdown Tau by ubiquitination-proteasome degradation pathway.

    Mengchen Lu;Tian Liu;Qiong Jiao;Jianai Ji

  • ISOLATION AND CHARACTERIZATION OF CANCER STEM LIKE CELLS IN HUMAN GLIOBLASTOMA CELL LINES

    Lei Qiang;Yong Yang;Yan-Jun Ma;Fei-Hong Chen

  • Gambogic acid-induced G2/M phase cell-cycle arrest via disturbing CDK7-mediated phosphorylation of CDC2/p34 in human gastric carcinoma BGC-823 cells.

    Jun Yu;Qing-Long Guo;Qi-Dong You;Li Zhao

  • Discovery of potent Keap1-Nrf2 protein-protein interaction inhibitor based on molecular binding determinants analysis.

    Zheng-Yu Jiang;Meng-Chen Lu;Li Li Xu;Ting-Ting Yang

  • Gambogic acid inhibits proliferation of human lung carcinoma SPC-A1 cells in vivo and in vitro and represses telomerase activity and telomerase reverse transcriptase mRNA expression in the cells.

    Zhao-Qiu Wu;Qing-Long Guo;Qi-Dong You;Li Zhao

  • Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-6.

    Arduino A. Mangoni;Catherine Guillou;Jean Jacques Vanden Eynde;Christopher Hulme

  • Anti-hepatitis B virus activity of wogonin in vitro and in vivo.

    Qinglong Guo;Li Zhao;Qidong You;Yong Yang

  • Flavonoid baicalein suppresses adhesion, migration and invasion of MDA-MB-231 human breast cancer cells

    Ling Wang;Yun Ling;Yan Chen;Cheng-Ling Li

  • Differential apoptotic induction of gambogic acid, a novel anticancer natural product, on hepatoma cells and normal hepatocytes.

    Yong Yang;Lan Yang;Qi-Dong You;Fei-Fei Nie

  • Heat Shock Protein 90 Inhibitors: An Update on Achievements, Challenges, and Future Directions.

    Li Li;Lei Wang;Qi-Dong You;Xiao-Li Xu

  • Inhibition of human telomerase reverse transcriptase gene expression by gambogic acid in human hepatoma SMMC-7721 cells

    Qing-Long Guo;Sen-Sen Lin;Qi-Dong You;Hong-Yan Gu

  • Synthesis and evaluation of anti-tubercular and antibacterial activities of new 4-(2,6-dichlorobenzyloxy)phenyl thiazole, oxazole and imidazole derivatives. Part 2.

    Xiaoyun Lu;Xiaobo Liu;Baojie Wan;Scott G. Franzblau

  • Discovery and Development of Kelch-like ECH-Associated Protein 1. Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein–Protein Interaction Inhibitors: Achievements, Challenges, and Future Directions

    Zheng-Yu Jiang;Meng-Chen Lu;Qi-Dong You

  • Gambogic acid inhibits angiogenesis through suppressing vascular endothelial growth factor-induced tyrosine phosphorylation of KDR/Flk-1.

    Na Lu;Yong Yang;Qi-Dong You;Yun Ling

  • An inhibitor of the Keap1-Nrf2 protein-protein interaction protects NCM460 colonic cells and alleviates experimental colitis.

    Meng-Chen Lu;Jian-Ai Ji;Yong-Lin Jiang;Zhi-Yun Chen

  • Drug resistance associates with activation of Nrf2 in MCF-7/DOX cells, and wogonin reverses it by down-regulating Nrf2-mediated cellular defense response.

    Yan Zhong;Fengyi Zhang;Zhongying Sun;Wei Zhou

Frequent Co-Authors

Qinglong Guo
Qinglong Guo China Pharmaceutical University
Na Lu
Na Lu China Pharmaceutical University
Minyong Li
Minyong Li Shandong University
Scott G. Franzblau
Scott G. Franzblau University of Illinois at Chicago
Jing Zhao
Jing Zhao University of Macau
Lucia Altucci
Lucia Altucci University of Campania "Luigi Vanvitelli"
Guangji Wang
Guangji Wang China Pharmaceutical University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Qidong You

Trending Scientists

Recently Published Articles